-
-
-
-
-
-
-
Lilly announces three acquisitions to build infectious disease portfolio
-
-
-
-
-
-
-
Eli Lilly & Co. (LLY) Tops Q1 EPS by $1.58, Beats on Revenue; Offers Strong Guidance
-
-
-
-
-
-
-
Lilly to acquire Kelonia Therapeutics for up to $7 billion
-
-
-
-
-
-
-
Large cap pharma defensive AI winner, says RBC as it backs Lilly & AbbVie
-
-
-
-
-
-
-
Novo Nordisk jumps, Hims shares plummet after pulling $49 weight-loss pill
-
-
-
-
-
-
-
Lilly confirms date and conference call for fourth-quarter 2025 financial results announcement
-
-
-
-
-
-
-
Eli Lilly upgraded at Leerink on 'multiple waves' of obesity drug adoption
-
1,206,073 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

